drugset / Trial / NCT00309062
Safety and Efficacy of Recombinant Birch Pollen Allergen in the Treatment of Allergic Rhinoconjunctivitis
RandomizedParallel-groupDouble-blindTreatment
Summary
Safety and efficacy of recombinant birch pollen allergen in the treatment of allergic rhinoconjunctivitis
Timeline
- Start
- 2003-12
- Primary completion
- 2006-06
- Completion
- 2009-06
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | Recombinant birch pollen | Protein / enzyme biologic | — | — |
Indications
No indication recorded.